Aetna modified CPB 0236 governing spine MRI and CT coverage, effective September 26, 2025. Here's what billing teams need to act on before claims start denying.
Aetna, a CVS Health company, updated its spine imaging coverage policy under CPB 0236 in the Aetna MRI and CT spine coverage policy. This revision affects 18 covered CPT codes—including 72141 through 72158 for spinal MRI and 72125 through 72133 for spinal CT—plus seven HCPCS contrast agent codes. If your practice bills spine imaging to Aetna members, review your documentation protocols against the updated criteria now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) of the Spine |
| Policy Code | CPB 0236 Aetna |
| Change Type | Modified |
| Effective Date | September 26, 2025 |
| Impact Level | High |
| Specialties Affected | Radiology, Neurology, Orthopedic Surgery, Neurosurgery, Pain Management, Primary Care |
| Key Action | Audit spine imaging documentation against the updated 18-criteria medical necessity list before billing CPT 72125–72158 or 72141–72158 to Aetna |
Aetna Spine MRI and CT Coverage Criteria and Medical Necessity Requirements 2025
The real issue with the CPB 0236 Aetna system update is the specificity of the medical necessity criteria. Aetna covers spine MRI and CT when a patient meets any one of 18 distinct clinical indications. That "any one" threshold sounds permissive—but each criterion carries documentation requirements your providers must satisfy before you bill.
Here is what Aetna's updated coverage policy requires. The patient's record must show clinical evidence of at least one of the following:
| # | Covered Indication |
|---|---|
| 1 | Clinical evidence of spinal stenosis |
| 2 | Clinical suspicion of spinal cord or cauda equina compression syndrome |
| 3 | Congenital anomalies or deformities of the spine |
| 4 | Diagnosis and evaluation of lumbar epidural lipomatosis |
| 5 | Evaluation of recurrent symptoms after spinal surgery |
| 6 | Evaluation prior to epidural injection to rule out tumor or infection and to identify the optimal injection site |
| 7 | Follow-up evaluation for spinal malignancy or spinal infection |
| 8 | Known or suspected myelopathy (e.g., multiple sclerosis) for initial diagnosis when brain MRI is negative or symptoms mimic other spinal or brainstem lesions |
| 9 | Known or suspected primary spinal cord tumors (malignant or non-malignant) |
| 10 | Persistent back or neck pain with radiculopathy—pain plus objective findings of motor or reflex changes in the specific nerve root distribution—with no improvement after six weeks of conservative therapy |
| 11 | Primary spinal bone tumors or suspected vertebral, paraspinal, or intraspinal metastases |
| 12 | Progressively severe symptoms despite conservative management |
| 13 | Rapidly progressing neurological deficit or major motor weakness |
| 14 | Severe back pain requiring hospitalization |
| 15 | Spondylolisthesis and degenerative disease of the spine that has not responded to four weeks of conservative therapy |
| 16 | Suspected infectious process (e.g., osteomyelitis or epidural abscess of the spine or soft tissue) |
| 17 | Suspected spinal cord injury secondary to trauma |
| 18 | Suspected spinal fracture or dislocation secondary to trauma when plain films are not conclusive |
| 19 | Suspected transverse myelitis |
Two criteria carry explicit conservative therapy timelines. "Conservative therapy" is defined by the policy as moderate activity, analgesics, NSAIDs, and muscle relaxants. Document all four components—not just one. If your provider only documented NSAIDs and the patient failed to return for six weeks, that's not sufficient. The record must reflect the full conservative therapy protocol.
This is where claim denial risk concentrates. Radiculopathy claims billing CPT 72148 or 72158 for lumbar MRI are the most commonly denied spine imaging claims. The culprit is almost always a missing timeline or incomplete documentation of objective neurological findings.
Spine MRI and CT billing reimbursement depends entirely on the strength of the clinical record attached to these codes. Aetna's prior authorization process will scrutinize exactly these criteria. If prior authorization is required for your patient's plan, submit documentation that maps directly to one of the 18 indications above—by name, not just by diagnosis code.
Aetna Spine Imaging Exclusions and Non-Covered Indications
One code in this policy is explicitly not covered for any indication listed in CPB 0236: G0566, the algorithm-derived 3D radiodensity-value bone imaging code from prior MRI examination data.
Do not bill G0566 under this policy. It appears in the code table specifically as excluded. If your radiology or AI-assisted imaging workflow generates this code in the context of spine studies, pull it from your charge capture for Aetna claims.
CPT 76390 (magnetic resonance spectroscopy) also appears in the policy as a related code but sits outside the covered/not-covered designation. It is listed for reference only. Do not assume it carries the same coverage status as the primary spine MRI codes.
Coverage Indications at a Glance
| Indication | Status | Notes |
|---|---|---|
| Clinical evidence of spinal stenosis | Covered | Document objective clinical findings |
| Spinal cord or cauda equina compression (suspected) | Covered | Clinical suspicion must be documented |
| Congenital spine anomalies or deformities | Covered | Diagnosis must be established or suspected |
| Lumbar epidural lipomatosis | Covered | For diagnosis and evaluation |
| Recurrent symptoms after spinal surgery | Covered | Prior surgical history required in record |
| Pre-epidural injection evaluation (rule out tumor/infection) | Covered | Must document reason for injection and anatomical need |
| Follow-up for spinal malignancy or infection | Covered | Active diagnosis required |
| Known/suspected myelopathy (e.g., MS) — brain MRI negative | Covered | Brain MRI result must be in record |
| Known/suspected primary spinal cord tumors | Covered | Malignant or non-malignant |
| Radiculopathy with objective neurological findings — no improvement after 6 weeks conservative therapy | Covered | Must document motor/reflex changes + full conservative therapy protocol |
| Primary spinal bone tumors or suspected metastases | Covered | Vertebral, paraspinal, or intraspinal |
| Progressively severe symptoms despite conservative management | Covered | Document treatment failure |
| Rapidly progressing neurological deficit or major motor weakness | Covered | Urgency supports same-day authorization |
| Severe back pain requiring hospitalization | Covered | Hospitalization itself is supporting documentation |
| Spondylolisthesis or degenerative spine disease — no improvement after 4 weeks conservative therapy | Covered | Must document 4-week conservative therapy |
| Suspected infectious process (osteomyelitis, epidural abscess) | Covered | Soft tissue infections included |
| Suspected spinal cord injury from trauma | Covered | Trauma mechanism must be documented |
| Suspected spinal fracture/dislocation from trauma — plain films inconclusive | Covered | Include plain film results in documentation |
| Suspected transverse myelitis | Covered | Clinical suspicion sufficient |
| 3D radiodensity bone imaging algorithm (G0566) | Not Covered | Explicitly excluded from CPB 0236 |
Aetna Spine MRI and CT Billing Guidelines and Action Items 2025
Spine MRI and CT billing under the updated CPB 0236 Aetna policy requires specific process changes before the September 26, 2025 effective date. Here is what your team needs to do now.
1. Pull G0566 from your Aetna charge capture immediately.
This code is explicitly not covered under CPB 0236. Any automated charge capture that appends G0566 to spine imaging workflows will generate denials. Remove it from Aetna-specific charge master entries before September 26, 2025.
2. Build the six-week and four-week timelines into your prior auth intake forms.
For radiculopathy cases (CPT 72148, 72158, 72141), the record must show failed conservative therapy over six weeks. For spondylolisthesis and degenerative disease, the threshold is four weeks. If your intake form does not prompt for this timeline, update it. Reviewers at Aetna will look for these dates when processing prior authorization requests.
3. Update documentation templates to capture all four conservative therapy components.
"Conservative therapy" under this policy means moderate activity, analgesics, NSAIDs, and muscle relaxants. A template that only captures "conservative treatment" as a checkbox does not support the claim. Physicians need to document which components were tried and for how long.
4. Verify contrast agent billing codes against the approved HCPCS list.
Aetna covers seven HCPCS contrast agents under this policy: A9575, A9576, A9577, A9578, A9579, Q9953, and Q9954. Cross-check your contrast agent charge codes against this list. If you use a contrast agent not on this list, expect a denial. Check your charge master now.
5. For pre-epidural injection imaging, document both the indication and the injection plan.
CPT 72148 or 72141 billed before an epidural injection requires documentation of two things: the reason for imaging (ruling out tumor or infection) and the goal of delineating the optimal injection site. Half-complete documentation will not support medical necessity.
6. Flag suspected infectious or malignant spine cases for expedited authorization.
Osteomyelitis, epidural abscess, spinal metastases, and primary spinal cord tumors all qualify for coverage. These cases often have urgent timelines. Know your Aetna contacts for expedited prior auth so you are not waiting 72 hours when the patient is admitted.
7. If your billing volume for spine imaging is high, loop in your compliance officer.
The criteria update touches 18 clinical indications and 543 ICD-10 codes. If spine imaging is a significant revenue line for your practice or health system, have your compliance officer review your documentation policies against the updated CPB 0236 criteria before the effective date of September 26, 2025.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Spine MRI and CT Under CPB 0236
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 72125 | CPT | Computed tomography, cervical spine; without contrast material |
| 72126 | CPT | Computed tomography, cervical spine; with contrast material |
| 72127 | CPT | Computed tomography, cervical spine; without contrast material, followed by contrast material(s) and further sections |
| 72128 | CPT | Computed tomography, thoracic spine; without contrast material |
| 72129 | CPT | Computed tomography, thoracic spine; with contrast material |
| 72130 | CPT | Computed tomography, thoracic spine; without contrast material, followed by contrast material(s) and further sections |
| 72131 | CPT | Computed tomography, lumbar spine; without contrast material |
| 72132 | CPT | Computed tomography, lumbar spine; with contrast material |
| 72133 | CPT | Computed tomography, lumbar spine; without contrast material, followed by contrast material(s) and further sections |
| 72141 | CPT | MRI, spinal canal and contents, cervical; without contrast material |
| 72142 | CPT | MRI, spinal canal and contents, cervical; with contrast material(s) |
| 72146 | CPT | MRI, spinal canal and contents, thoracic; without contrast material |
| 72147 | CPT | MRI, spinal canal and contents, thoracic; with contrast material(s) |
| 72148 | CPT | MRI, spinal canal and contents, lumbar; without contrast material |
| 72149 | CPT | MRI, spinal canal and contents, lumbar; with contrast material(s) |
| 72156 | CPT | MRI, spinal canal and contents, cervical; without contrast material, followed by contrast material(s) and further sections |
| 72157 | CPT | MRI, spinal canal and contents, thoracic; without contrast material, followed by contrast material(s) and further sections |
| 72158 | CPT | MRI, spinal canal and contents, lumbar; without contrast material, followed by contrast material(s) and further sections |
Not Covered / Excluded Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| G0566 | HCPCS | 3D radiodensity-value bone imaging, algorithm derived, from previous magnetic resonance examination | Not covered for any indication listed in CPB 0236 |
Covered HCPCS Contrast Agent Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| A9575 | HCPCS | Injection, gadoterate meglumine, 0.1 ml |
| A9576 | HCPCS | Injection, gadoteridol (ProHance multipack), per ml |
| A9577 | HCPCS | Injection, gadobenate dimeglumine (MultiHance), per ml |
| A9578 | HCPCS | Injection, gadobenate dimeglumine (MultiHance multipack), per ml |
| A9579 | HCPCS | Injection, gadolinium-based MRI contrast agent, not otherwise specified, per ml |
| Q9953 | HCPCS | Injection, iron-based MRI contrast agent, per ml |
| Q9954 | HCPCS | Oral MRI contrast agent, per 100 ml |
Key ICD-10-CM Diagnosis Codes
The full policy includes 543 ICD-10-CM codes. Below are the highest-volume and highest-risk diagnosis categories your billing team should map to spine imaging claims.
| Code / Range | Description |
|---|---|
| A18.01, A18.03 | Tuberculosis of spine and other bones |
| C40.00–C41.9 | Malignant neoplasm of bone and articular cartilage |
| C41.2 | Malignant neoplasm of vertebral column |
| C41.4 | Malignant neoplasm of pelvic bones, sacrum, and coccyx |
| C70.1 | Malignant neoplasm of spinal meninges |
| C72.0, C72.1 | Malignant neoplasm of spinal cord |
| C79.51, C79.52 | Secondary malignant neoplasm of bone and bone marrow |
| C69.00–C72.59 | Malignant neoplasms of eye, brain, and other CNS |
| C76.0–C80.2 | Malignant neoplasms of ill-defined, other secondary, and unspecified sites |
| C45.0–C49.A9 | Malignant neoplasm of mesothelial and soft tissue |
| C50.011–C50.919 | Malignant neoplasm of breast (metastatic workup context) |
| C7A.0–C7A.36 | Malignant neuroendocrine tumors |
| C00.0–C14.8 | Malignant neoplasm of lip, oral cavity, and pharynx |
| C15.0–C26.9 | Malignant neoplasm of digestive organs |
| C30.0–C39.9 | Malignant neoplasm of respiratory and intrathoracic organs |
| C51.0–C58 | Malignant neoplasm of female genital organs |
| C60.0–C63.12 | Malignant neoplasm of male genital organs |
| C64.1–C68.9 | Malignant neoplasm of urinary tract |
| C73–C75.9 | Malignant neoplasm of thyroid and other endocrine glands |
The ICD-10 list skews heavily toward oncology because metastatic workup and primary spine tumor evaluation are two of the strongest coverage indications in this policy. Map your diagnosis codes carefully. A patient with a known primary malignancy and new back pain should carry both the primary cancer code and the appropriate spine symptom code.
Get the Full Picture for CPT 72125
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.